Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer

Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer

Abstract Background Mesenchymal-epithelial transition exon14 (METex14) skipping is one of the therapeutic driver oncogene mutations in non-small cell lung cancer (NSCLC), and can be treated with tepotinib and capmatinib. There is only one report on computed tomography (CT) findings of METex14 skippi...

Full description

Bibliographic Details
Main Authors: Naokazu Watari, Kakuhiro Yamaguchi, Hiroaki Terada, Kosuke Hamai, Ken Masuda, Yoshifumi Nishimura, Shinjiro Sakamoto, Takeshi Masuda, Yasushi Horimasu, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Hiroyasu Shoda, Nobuhisa Ishikawa, Kazunori Fujitaka, Kozue Miyazaki, Yoshihiro Miyata, Hironobu Hamada, Kazuo Awai, Noboru Hattori
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Pulmonary Medicine
Subjects:
Mesenchymal-epithelial transition exon14 skipping
Computed tomography
Non-small cell lung cancer
Driver gene mutation
Imaging examination
Online Access:https://doi.org/10.1186/s12890-022-02037-4

Internet

https://doi.org/10.1186/s12890-022-02037-4

Similar Items